QLGN News and Press, Qualigen Therapeutics Inc. From 01/26/21

Qualigen Therapeutics Announces Completion of Milestone Related to the License and Technology Transfer of its FastPack® Diagnostics Products in China PR Newswire CARLSBAD, Calif. , Jan. 26, 2021 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN),...

La Jolla Pharmaceutical (LJPC) +62% on exclusive licensing agreement with PAIONVOXX International (VOXX) +56% after posting strong sales growth.T2 Biosystems (TTOO) +33% after the company says its T2SARS-CoV-2 Panel is capable of detecting multiple variants of the COVID-19 viru...

Qualigen Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference PR Newswire CARLSBAD, Calif. , Jan. 5, 2021 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing novel therapeutics fo...

Qualigen Therapeutics Issues CEO Letter to Stockholders with 2021 Outlook PR Newswire CARLSBAD, Calif. , Dec. 22, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) , a biotechnology company focused on developing novel therapeutics for the t...

Qualigen Therapeutics, Inc. Announces Closing of $12 Million Registered Direct Offering PR Newswire CARLSBAD, Calif. , Dec. 18, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) today announced the closing of its previously announced r...

Qualigen Therapeutics ([[QLGN]] -8.4%) has entered into a definitive agreement with a single institutional investor for $12M direct offering, expected to close on Dec. 18, 2020.It includes sale and purchase of: (i) 2,370,786 Qualigen's common shares, (ii) 1,000,000 pre-funded w...

Qualigen Therapeutics, Inc. Announces $12 Million Registered Direct Offering CARLSBAD, Calif. , Dec. 16, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) ("Qualigen" or the "Company"), today announced it has entered into a definitive agreement wi...

Are These Small-Cap Stocks On Your December Watch List? Small-cap stocks are crushing milestones in 2020, which is why so many are looking for penny stocks to buy right now. While not all penny stocks are considered small caps, a good benchmark of health is the Russell 2000 ETF ...

Qualigen Therapeutics ([[QLGN]] +10.7%) announces that the United States Patent and Trademark Office has issued a patent related to its ALAN (Aptamer-Linked Anti-Nucleolin) technology.This patent issued protects the ALAN technology for use with cancer radiation therapy and for imaging tu...

Qualigen Therapeutics Announces Issuance of U.S. Patent for Expanded Applications of ALAN Anticancer Platform Technology CARLSBAD, Calif. , Dec. 15, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a biotechnology company focused on developing no...